FDA Investigates Drugs from Overseas
WASHINGTON-Facing Congressional criticism that it isn't doing enough to prevent counterfeit-drug imports, the Food and Drug Administration (FDA) is reviewing thousands of drug shipments from foreign countries. The FDA will be examining the drugs to see if counterfeit ingredients have made their way into US drug-making plants. Congressional concerns stem from the potential of substandard ingredients, manufactured in foreign drug plants, being used by the nation's drug makers. The FDA, while often not inspecting these drugs, says it has no evidence of a substantial problem, nor does it believe that the public is at any risk of harm from such substances. Also part of the investigation is increased enforcement and warnings to importers to help regulators keep track of shipments. For more information, visit www.fda.gov.
Revolutionizing Hospital Cleanliness: How Color Additives Transform Infection Prevention
December 9th 2024Discover how a groundbreaking color additive for disinfectant wipes improved hospital cleanliness by 69.2%, reduced microbial presence by nearly half, and enhanced cleaning efficiency—all without disrupting workflows.
Splash Pads and Waterborne Disease Outbreaks: A 25-Year Perspective Introduction
December 5th 2024A CDC report reveals 25 years of splash pad-linked waterborne outbreaks, highlighting risks from pathogens like Cryptosporidium. Prevention requires better hygiene, water treatment, and public health strategies.
Piloting Change Management: Tools for Infection Preventionists to Drive Impactful Change
December 5th 2024Infection preventionists play a vital role in health care, leveraging change management techniques to overcome resistance, unite stakeholders, and implement strategies prioritizing patient safety.
